Product
DE-130A/DE-130A
1 clinical trial
2 indications
Indication
Open-Angle GlaucomaIndication
Ocular Surface DiseaseClinical trial
A Phase III, Multinational, Multicenter, Investigator-Masked, Randomized, Active Controlled Trial, Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension Over a 3-Month Period, Followed by a 12-Month Follow-Up With Open-Label DE-130A Treatment.Status: Completed, Estimated PCD: 2022-02-03